Search Within

Rahim Hirani

Formats
  1. Meeting Abstract (7)
  2. Journal Article (5)
  3. Editorial (1)
Groups
  1. Department of Medicine (9)
  2. Genitourinary Oncology Service (9)
  3. Sloan Kettering Institute Postdocs (9)
  4. Solid Tumor Oncology Division (9)
  5. Epidemiology and Biostatistics (4)
  6. GME, Surgery (4)

More Groups

People
  1. Philip Kantoff (9)
  2. Ying Mazzu (9)
  3. Goutam Chakraborty (8)
  4. Subhiksha Nandakumar (8)
  5. Lina Jehane (7)
  6. Sai Harisha Rajanala (7)

More People

Years
  1. 2023 (3)
  2. 2022 (3)
  3. 2021 (4)
  4. 2020 (3)
Publications
  1. Cancer Research (3)
  2. Clinical Cancer Research (3)
  3. Gynecologic Oncology (3)
  4. Journal of Clinical Oncology (2)
  5. Journal of Gynecologic Surgery (1)
  6. Molecular Oncology (1)
Publishers
  1. American Association for Cancer Research (6)
  2. Elsevier Inc. (3)
  3. American Society of Clinical Oncology (2)
  4. FEBS Press (1)
  5. Mary Ann Liebert, Inc (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Praiss, A. M.; Hirani, R.; Zhou, Q.; Iasonos, A.; Sonoda, Y.; Abu-Rustum, N. R.; Leitao, M. M. Jr; Long Roche, K.; Broach, V.; Gardner, G. J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Impact of postoperative morbidity on oncologic outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery
    Meeting Abstract

    Hirani, R.; Praiss, A.; Choi, K.; Zhou, Q.; Iasonos, A.; Gardner, G.; Roche, K. L.; Sonoda, Y.; Chi, D.; Zivanovic, O.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Perioperative percent change in CA-125 in patients with high grade serous ovarian cancer undergoing primary cytoreductive surgery with complete gross resection
    Meeting Abstract

    Hirani, R.; Praiss, A.; Choi, K.; Gardner, G.; Roche, K. L.; Sonoda, Y.; Chi, D.; Zivanovic, O.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Letter to the editor: Physician's dilemma and reproductive health medical training post Roe v. Wade reversal
    Editorial

    Hirani, Rahim; Khuram, Hassan; Praiss, Aaron M.; Grimes, Cara L.
    Journal of Gynecologic Surgery (2022)

    Fulltext@MSK | Save
  • Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer
    Journal Article

    Yoshikawa, Y.; Stopsack, K. H.; Wang, X. V.; Chen, Y. H.; Mazzu, Y. Z.; Burton, F.; Chakraborty, G.; Rajanala, S. H.; Hirani, R.; Nandakumar, S.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors
    Journal Article

    Chakraborty, G.; Khan Patail, N.; Hirani, R.; Nandakumar, S.; Mazzu, Y. Z.; Yoshikawa, Y.; Atiq, M.; Jehane, L. E.; Stopsack, K. H.; Lee, G. S. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save